Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
PLUS THERAPEUTICS, INC. has filed 1,451 SEC EDGAR filings since 30 Mar 2001

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
3

FORM 3

Filing date
03 May 2011
Reporting date
29 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

FORM 8-K

Filing date
03 May 2011
Reporting date
28 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 May 2011
Reporting date
28 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-34375

CYTORI THERAPEUTICS INC DEF 14A 8-16-2011

Filing date
02 May 2011
Reporting date
16 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-172787

FORM S-3

Filing date
11 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-34375

CYTORI THERAPEUTICS, INC. FORM 10K YEAR ENDED 12-31-2010

Filing date
11 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K FILED 3-10-2011

Filing date
10 Mar 2011
Reporting date
10 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K FILED 02-28-2011

Filing date
04 Mar 2011
Reporting date
28 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2011
Reporting date
28 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2011
Reporting date
28 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2011
Reporting date
28 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2011
Reporting date
28 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80327

CYTORI

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-80327

SC 13G filing

Filing date
04 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Feb 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
03 Feb 2011
Reporting date
18 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .